Who owns RTI Biologics?

Key details on RTI Biologics (Ticker: RTIX)

Who owns RTI Biologics?

Is RTIX a good stock to own? Find out who bought RTI Biologics, who sold RTI Biologics (RTIX) stock, and who holds a large position in RTI Biologics.

Fund Name Number of Shares Share Valuation As Of
Paradigm Capital Management 5.48M $19.39M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 3.25M $11.49M Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 3.18M $11.26M Dec. 31, 2013
KOPP FUNDS 2.17M $7.67M Dec. 31, 2013
Kopp Investment Advisors 2.17M $7.67M Dec. 31, 2013
Royce & Associates 2.13M $7.55M Dec. 31, 2013
GAGNON SECURITIES 1.95M $6.91M Dec. 31, 2013
Tamarack Capital Management 1.73M $6.11M Dec. 31, 2013
Fort Washington Investment Advisors 1.58M $5.92M June 30, 2013
BlackRock Fund Advisors 1.56M $5.51M Dec. 31, 2013
Frank Russell Company 1.53M $4.80M Dec. 31, 2013
First Light Asset Management 1.41M $4.97M Dec. 31, 2013
Vanguard 1.37M $4.85M Dec. 31, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.35M $4.78M Dec. 31, 2013
STATE STREET CORPORATION 1.21M $5.16M Dec. 31, 2013
JPMORGAN CHASE & CO 1.10M $4.12M June 30, 2012
HealthCor Management 1.01M $2.75M June 30, 2011
Gagnon Advisors 954336 $3.38M Dec. 31, 2013
NorthPointe Capital 935209 $3.99M Dec. 31, 2012
KENNEDY CAPITAL MANAGEMENT 913457 $3.23M Dec. 31, 2013
OppenheimerFunds 892691 $3.72M Sept. 30, 2012
Teachers Advisors 851244 $3.15M March 31, 2012
Principal Financial 850440 $3.01M Dec. 31, 2013
Heartland Advisors 825801 $2.82M June 30, 2013
NORTHERN TRUST 771884 $2.74M Dec. 31, 2013
Signia Capital Management 768222 $2.72M Dec. 31, 2013

Who sold RTI Biologics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Accipiter Capital Management June 30, 2011 1.75M $4.74M
Manulife Asset Management June 30, 2011 1.42M $3.84M
HealthCor Management June 30, 2011 1.01M $2.75M
Wells Fargo & Company March 31, 2011 816764 $2.34M
Ramius March 31, 2011 770500 $2.20M
FMR Dec. 31, 2010 8.21M $21.92M
Cortina Asset Management Dec. 31, 2010 1.08M $2.89M